ClinicalTrials.govclosed

Osimertinib and Bevacizumab Versus Osimertinib Alone as Second-line Treatment in Stage IIIb-IVb NSCLC With Confirmed EGFRm and T790M

ClinicalTrials.gov study NCT03133546. IPD Sharing: NO. Countries: 6. Publications: 6.

ShareScore

36/100

Overall dataset sharing score

Score breakdown

These five areas show where the dataset supports — or may limit — practical reuse.

Stewardship: 12
Harmonization: 12
Access: 4
Reuse readiness: 0
Engagement: 8

Topics

clinical trial NIH ClinicalTrials.gov

Dataset details

Repository: ClinicalTrials.gov
Published: February 11, 2026
License: IPD-NO
DOI: clinicaltrials.gov/NCT03133546

Scored with release 0.9.0

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.

Start your CV How the NIH biosketch works